News & Articles

The Simplexa™ SARS-CoV-2 Variants Direct assay aims to enable detection of four mutations associated with virus variants without requiring upfront RNA extraction

The availability of an International Standard (IS) for antibodies facilitates the standardization of SARS-CoV-2 serological methods

The independent study is being led by Southampton University Health Sciences

In a Phase 3 trial, the vaccine was 100% effective and generally well tolerated in participants aged 12 to 15 years

Vaccine, trialed in 450 children, shows favorable safety profile and was well-tolerated

COVID-19 infections fell by 65% percent after a first dose of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines in this large community surveillance study

Sensor could be used in discovering new treatments for mental illness, in neuroscience research and to detect drugs of abuse

The researchers noted that caffeine is believed to cause blood vessels in the uterus and placenta to constrict

Investigational antibody cocktail of casirivimab and imdevimab also significantly shortened the duration of symptoms by four days

Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing

The assay has the ability to sequence and surveil evolution of virus mutations over time and geography

This study offers new insights into high grade serous ovarian cancer that have the potential to make an impact in how patients are treated in the future

This partnership aims to offer an accelerated route to market rapid test technologies

Lenco Diagnostic Laboratories among first to offer Beckman Coulter’s semi-quantitative antibody test

Oxford-AstraZeneca coronavirus vaccine 79% effective against symptomatic COVID-19 overall

The monthly safety report will be made public on the European Medicines Agency website

The findings come from the largest study to date to look at inflammatory markers in COVID-19